1242134-19-5

Basic information

• Product Name: 4-bromo-2-sulfamoylbenzoic acid
• CAS NO: 1242134-19-5
• Molecular Weight: 280.099
• Mol File: 1242134-19-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-bromo-2-sulfamoylbenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-2-sulfamoylbenzoic acid(1242134-19-5)
• EPA Substance Registry System: 4-bromo-2-sulfamoylbenzoic acid(1242134-19-5)

Safety Data

• Hazardous Substances Data: 1242134-19-5(Hazardous Substances Data)

Upstream product

• 69321-56-8 5-bromo-2-methyl-benzene-sulfonyl chloride 
• 106-38-7 para-bromotoluene 
• 56919-16-5 5-bromo-2-methylbenzene-1-sulfonamide 

Relevant articles and documents

INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF CANCER

The invention relates to compounds of formula (I): wherein R1; R2, R3, R4, R5 and are as defined in the description. The compounds of formula (I) are inhibitors of the YAP/TAZ-TEAD interaction and thu

SUBSTITUTED HETEROCYCLIC ACETAMIDES AS KAPPA OPIOID RECEPTOR (KOR) AGONISTS

The present invention relates to a series of substituted compounds having the general formula (I), including their ste reoisomers and/or their pharmaceutically acceptable salts, wherein R1, R2, R3. R4, R5, and R6 are as defined herein. This invention also relates to methods of making these compounds including intermediates. The compounds of this invention are effective at the kappa (κ) opioid receptor (KOR) site. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic pain, and associated disorders, particularly functioning peripherally at the CNS.